CLEAN SCIENCE & TECH | TATVA CHINTAN PHARMA | CLEAN SCIENCE & TECH/ TATVA CHINTAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 54.8 | 77.0 | 71.3% | View Chart |
P/BV | x | 13.8 | 5.6 | 245.3% | View Chart |
Dividend Yield | % | 0.4 | 0.2 | 236.2% |
CLEAN SCIENCE & TECH TATVA CHINTAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
CLEAN SCIENCE & TECH Mar-23 |
TATVA CHINTAN PHARMA Mar-23 |
CLEAN SCIENCE & TECH/ TATVA CHINTAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2,079 | 2,649 | 78.5% | |
Low | Rs | 1,227 | 1,606 | 76.4% | |
Sales per share (Unadj.) | Rs | 88.1 | 191.1 | 46.1% | |
Earnings per share (Unadj.) | Rs | 27.8 | 20.5 | 135.4% | |
Cash flow per share (Unadj.) | Rs | 31.2 | 24.8 | 125.6% | |
Dividends per share (Unadj.) | Rs | 5.00 | 2.00 | 250.0% | |
Avg Dividend yield | % | 0.3 | 0.1 | 321.7% | |
Book value per share (Unadj.) | Rs | 94.9 | 232.2 | 40.9% | |
Shares outstanding (eoy) | m | 106.24 | 22.17 | 479.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 18.8 | 11.1 | 168.6% | |
Avg P/E ratio | x | 59.5 | 103.7 | 57.4% | |
P/CF ratio (eoy) | x | 53.0 | 85.7 | 61.9% | |
Price / Book Value ratio | x | 17.4 | 9.2 | 190.1% | |
Dividend payout | % | 18.0 | 9.7 | 184.7% | |
Avg Mkt Cap | Rs m | 175,632 | 47,157 | 372.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 452 | 386 | 117.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 9,358 | 4,236 | 220.9% | |
Other income | Rs m | 298 | 57 | 519.2% | |
Total revenues | Rs m | 9,656 | 4,294 | 224.9% | |
Gross profit | Rs m | 4,025 | 572 | 703.7% | |
Depreciation | Rs m | 361 | 96 | 377.7% | |
Interest | Rs m | 6 | 86 | 6.5% | |
Profit before tax | Rs m | 3,956 | 448 | 883.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,005 | -7 | -14,189.1% | |
Profit after tax | Rs m | 2,952 | 455 | 648.9% | |
Gross profit margin | % | 43.0 | 13.5 | 318.6% | |
Effective tax rate | % | 25.4 | -1.6 | -1,606.0% | |
Net profit margin | % | 31.5 | 10.7 | 293.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6,303 | 3,136 | 201.0% | |
Current liabilities | Rs m | 1,155 | 2,361 | 48.9% | |
Net working cap to sales | % | 55.0 | 18.3 | 301.0% | |
Current ratio | x | 5.5 | 1.3 | 411.0% | |
Inventory Days | Days | 144 | 3 | 4,909.5% | |
Debtors Days | Days | 57 | 73 | 78.4% | |
Net fixed assets | Rs m | 5,215 | 4,304 | 121.2% | |
Share capital | Rs m | 106 | 222 | 47.9% | |
"Free" reserves | Rs m | 9,981 | 4,926 | 202.6% | |
Net worth | Rs m | 10,087 | 5,148 | 196.0% | |
Long term debt | Rs m | 0 | 42 | 0.0% | |
Total assets | Rs m | 11,518 | 7,439 | 154.8% | |
Interest coverage | x | 710.0 | 6.2 | 11,439.3% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.8 | 0.6 | 142.7% | |
Return on assets | % | 25.7 | 7.3 | 353.2% | |
Return on equity | % | 29.3 | 8.8 | 331.2% | |
Return on capital | % | 39.3 | 10.3 | 381.9% | |
Exports to sales | % | 71.7 | 76.2 | 94.1% | |
Imports to sales | % | 10.8 | 56.9 | 19.0% | |
Exports (fob) | Rs m | 6,713 | 3,229 | 207.9% | |
Imports (cif) | Rs m | 1,010 | 2,409 | 41.9% | |
Fx inflow | Rs m | 6,713 | 3,229 | 207.9% | |
Fx outflow | Rs m | 1,010 | 2,409 | 41.9% | |
Net fx | Rs m | 5,703 | 820 | 695.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,794 | 278 | 1,005.5% | |
From Investments | Rs m | -2,698 | -1,011 | 266.8% | |
From Financial Activity | Rs m | -550 | 378 | -145.6% | |
Net Cashflow | Rs m | -455 | -357 | 127.6% |
Indian Promoters | % | 75.0 | 72.0 | 104.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 10.9 | 16.5 | 66.2% | |
FIIs | % | 5.9 | 3.7 | 161.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 25.0 | 28.0 | 89.4% | |
Shareholders | 279,395 | 73,730 | 378.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare CLEAN SCIENCE & TECH With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES GHCL
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | CLEAN SCIENCE & TECH | TATVA CHINTAN PHARMA |
---|---|---|
1-Day | -0.36% | 0.02% |
1-Month | -0.07% | 9.97% |
1-Year | -6.65% | -23.68% |
3-Year CAGR | -6.10% | -18.73% |
5-Year CAGR | -3.71% | -11.70% |
* Compound Annual Growth Rate
Here are more details on the CLEAN SCIENCE & TECH share price and the TATVA CHINTAN PHARMA share price.
Moving on to shareholding structures...
The promoters of CLEAN SCIENCE & TECH hold a 75.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CLEAN SCIENCE & TECH and the shareholding pattern of TATVA CHINTAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, CLEAN SCIENCE & TECH paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 18.0%.
TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.
You may visit here to review the dividend history of CLEAN SCIENCE & TECH, and the dividend history of TATVA CHINTAN PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.